Verquvo (vericiguat)

pCPA File Number: 22399

Negotiation Status:

Concluded with an LOI

Indication(s):

Symptomatic chronic heart failure in adult patients with reduced ejection fraction who are stabilized after a recent heart failure decompensation event requiring hospitalization and/or intravenous diuretic therapy

Sponsor/Manufacturer:

Bayer Inc.

CDA-AMC Project Number:

SR0758-000

pCPA Engagement Letter Issued:

2023-12-18

Negotiation Process Concluded:

2024-06-28